Esterified Saccharide Compounds TRIZ Cases

Stepwise synthesis creates homogeneous heparin mimetics with controlled sulfation, supporting coagulation inhibition and FGF-2 binding.

This case uses supported α-L-rhamnosidase to convert di-rhamnolipids selectively, improving yield while avoiding unwanted side products.

Room-temperature trimethylsilyl protection and partial acylation streamline unnatural sugar synthesis for cleaner metabolic labeling.

Specific beta-1,6-D-glucan oligomer structures enhance IgG2 antibody recognition to resolve insufficient targeting specificity in cancer therapies.

Sugar alcohol ester pro-drugs enhance corneal penetration by balancing solubility and hydrophobicity to treat glaucoma effectively.

Zinc bromide catalyzes acyl group introduction and halogen substitution on unprotected D-glucose in a single reaction step.

Coupling organotin groups to an inorganic carrier enables direct filtration after quenching, eliminating complex distillation steps.

Metabolic incorporation of trans-cyclooctene groups avoids toxic reagents while enabling stable covalent attachment to cell surfaces.

Polar aprotic solvent removes water from sucrose reaction mixtures at low temperatures, eliminating non-polar co-solvents that cause carbohydrate decomposition.

Protected esterification of mycolic acids yields pure single isomers, resolving mixture complexity.

Synthetic ASLA molecules compete with bacterial lipids for TLR4 binding, inhibiting inflammation and lowering sepsis mortality rates.

Water-insoluble cellulose alkyl sulfonate fibers provide instantaneous fluid absorption and retention without ion exchange.

N-position modified mebendazole prodrugs enhance aqueous solubility to resolve poor oral bioavailability barriers in cancer treatment.